Depression
Depression and cannabis have a complex, bidirectional relationship. While many people use cannabis to self-medicate depressive symptoms, the evidence for long-term benefit is mixed and heavy use may worsen depression in some individuals.
Quick Reference
Short-Term Mood Effects
In the short term, low-dose THC produces mood elevation, increased sociability and euphoria through increased dopamine release in the reward pathway. CBD has demonstrated antidepressant-like effects in multiple animal models, primarily through its interaction with serotonin 5-HT1A receptors — the same target as SSRIs. Several observational studies of medical cannabis patients report significant improvements in depressive symptoms. The challenge is that most of these studies cannot distinguish between direct antidepressant effects and relief of co-morbid pain or anxiety that was driving depressive symptoms.
Long-Term Use and Mood
The picture with long-term cannabis use and depression is concerning. Heavy, frequent cannabis use is associated with increased risk of developing depression, particularly in young people. A 2020 meta-analysis found daily cannabis users had twice the risk of depression compared to non-users. Chronic THC exposure reduces CB1 receptor density in the prefrontal cortex — an area critical for mood regulation and motivation. This receptor downregulation may explain why heavy users often report anhedonia (inability to feel pleasure) and dysphoria during abstinence.
The Endocannabinoid System and Mood
The endocannabinoid system is thought to play a significant role in depression. Post-mortem studies show reduced CB1 receptor density in the prefrontal cortex of people who died with depression. Stress depletes endocannabinoid tone, and cannabis may temporarily restore this. However, externally supplied cannabinoids downregulate the body's own system over time — making external supply necessary for normal mood function. This is the dependency trap relevant to cannabis and depression.
CBD and Depression
CBD shows more promise than THC for depression, due to its serotonin receptor activity and absence of tolerance development. A Brazilian clinical trial found CBD (300mg/day) as effective as imipramine (a tricyclic antidepressant) in reducing depressive behaviour in an animal model. Human clinical trials of CBD for depression are underway but results are not yet conclusive. CBD is generally safe to use alongside conventional antidepressants, though dose adjustments may be needed due to CYP450 interactions.
Evidence-Based Guidance
If you are experiencing depression, the first-line treatments remain psychotherapy (particularly CBT) and, where appropriate, antidepressant medication — both with stronger evidence bases than cannabis. If you are considering cannabis for depression, CBD-dominant preparations are preferred over THC-dominant ones. Avoid daily high-THC use. If you already use cannabis and notice it worsening your mood, discuss cessation with your doctor. Cannabis should not replace treatment for serious depression.